Our research strategy is to organize and manage a network of public and private best-in-class research teams, each of which has its own unique focus. We have segmented our primary research into modules, each of which is then outsourced, under our direct supervision, to high-level, specialized and complementary public and private research teams. We retain all intellectual property rights on the joint research and we apply for domestic and international patents whenever justified. As agreed and coordinated by us, the joint research teams are authorized to co-publish their results.

The research specialist groups which Mymetics has retained as partners include:

Strategic Industrial Partners
Pevion Biotech AG, Bern, Switzerland: virosome formulation under GMP conditions (Phase I to III).
Protein'eXpert SA, Grenoble, France: recombinant protein production under GMP conditions (Phase I and II).
Becton Dickinson Inc., Grenoble, France and Durham, NC, USA: vaccine delivery devices for human vaccination.

Strategic Academic/Govermental Partners
Dr. Morgane Bomsel, Institut Cochin, Paris, France: research on mucosa and the mucosal entry of HIV.
Dr. Lucia Lopalco, San Raffaele Scientific Institute, Milan, Italy: research on mucosal protection in HIV infected subjects.
Dr Dimiter Dimitrov, National Cancer Institute (NCI), Frederick, Maryland, USA: crystallization of Mymetics' recombinant gp41.
Dr Nancy Miller, NIAID-NIH, Bethesda, Maryland, USA: pre-clinical trial in macaque for evaluating Mymetics' vaccine candidate clade B and clade C combined together.
Dr. Fabienne Anjuère, University of Nice, Nice, France: monitoring of mucosal B lymphocytes.
Dr. Cecil Czerkinsky, International Vaccine Institute, Seoul, Republic of Korea: expertise in mucosa and technical standardization.
Dr. Eleonora Simeoni, EPFL, Lausanne, Switzerland: polymer nanoparticles development.
Dr. Jeffrey Alan Hubbell, EPFL, Lausanne, Switzerland: polymer nanoparticles development.

Technical Industrial Partners
Bachem AG, Basel, Switzerland: peptide synthesis under GMP conditions (Phase I to III),
Centre Lago, Vonnas, France: germ-free rabbit immunizations.
Monogram Biosciences, Inc. (formerly ViroLogic Inc.), San-Francisco, USA: PhenoSense neutralizing assay.

Technical Academic Partners
INRA (Dr. Pierre Coudert), Tours, France: rabbit immunizations
Chinese Academy of Medical Sciences, Institute of Laboratory Animal Science (Dr Quin Chuan), Beijing, China : Macaques immunizations.
INSERM (Dr. Christiane Moog), Strasbourg, France: classical neutralizing assay on T cells and macrophages.
Institut Cochin (Professor Uriel Hazan), Paris, France: research on the apoptotic